Ana Aslan National Institute of Grontology and Geriatrics

Ana Aslan National Institute of Gerontology and Geriatrics is the first Institute of Geriatrics and Gerontology in the world, founded by Prof Ana Aslan , MD, in 1952. The Institute treats more than 14,000 patients annually. The first drug created to delay the aging process, Gerovital H3, was developed by Ana Aslan, who initiated a complex, multidimensional approach to assess the phenomenon of human aging: the fundamental research of intimate processes at the cellular and sub-cellular levels involved in transformations that accompany aging; assessing changes in the human body over the years; the implications of the aging phenomenon at the...

Health care,geriatrics,and gerontology

Ana aslan national institute of grontology and geriatrics operates in the Hospitals and health care industry.

Ana aslan national institute of grontology and geriatrics's revenue is 11m - 100m

Ana aslan national institute of grontology and geriatrics has 11 - 50 employees.